117 related articles for article (PubMed ID: 37666030)
1. Antifungal activity of selective serotonin reuptake inhibitors against Cryptococcus spp. and their possible mechanism of action.
da Silva CR; do Amaral Valente Sá LG; Ferreira TL; Leitão AC; de Farias Cabral VP; Rodrigues DS; Barbosa AD; Moreira LEA; Filho HLP; de Andrade Neto JB; Rios MEF; Cavalcanti BC; Magalhães HIF; de Moraes MO; Vitoriano Nobre H
J Mycol Med; 2023 Nov; 33(4):101431. PubMed ID: 37666030
[TBL] [Abstract][Full Text] [Related]
2. In vitro anti-Candida activity of selective serotonin reuptake inhibitors against fluconazole-resistant strains and their activity against biofilm-forming isolates.
Costa Silva RA; da Silva CR; de Andrade Neto JB; da Silva AR; Campos RS; Sampaio LS; do Nascimento FBSA; da Silva Gaspar B; da Cruz Fonseca SG; Josino MAA; Grangeiro TB; Gaspar DM; de Lucena DF; de Moraes MO; Cavalcanti BC; Nobre Júnior HV
Microb Pathog; 2017 Jun; 107():341-348. PubMed ID: 28411060
[TBL] [Abstract][Full Text] [Related]
3. In vitro synergistic effects of fluoxetine and paroxetine in combination with amphotericin B against Cryptococcus neoformans.
Pereira TC; de Menezes RT; de Oliveira HC; de Oliveira LD; Scorzoni L
Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33417701
[TBL] [Abstract][Full Text] [Related]
4. Interactions between antifungals and everolimus against
Liang P; Song J; Liu Q
Front Cell Infect Microbiol; 2023; 13():1131641. PubMed ID: 37026056
[TBL] [Abstract][Full Text] [Related]
5. In vitro effects of selective serotonin reuptake inhibitors on Cryptococcus gattii capsule and biofilm.
Viveiro LRDG; Rehem AR; Santos ELS; Carmo PHFD; Junqueira JC; Scorzoni L
Pathog Dis; 2024 Feb; 82():. PubMed ID: 38204138
[TBL] [Abstract][Full Text] [Related]
6. Serotonin reuptake inhibitors effect on fluconazole activity against resistant Candida glabrata strains.
Alkhalifa BA; Bulatova NR; abuRokba W; Darwish RM
J Glob Antimicrob Resist; 2022 Jun; 29():49-54. PubMed ID: 35181564
[TBL] [Abstract][Full Text] [Related]
7. In vitro synergistic effect of minocycline combined with antifungals against Cryptococcus neoformans.
Tan L; Shi H; Chen M; Wang Z; Yao Z; Sun Y
J Mycol Med; 2022 Mar; 32(1):101227. PubMed ID: 34800920
[TBL] [Abstract][Full Text] [Related]
8.
Sun Y; Tan L; Yao Z; Gao L; Yang J; Zeng T
Microbiol Spectr; 2022 Feb; 10(1):e0200721. PubMed ID: 35019705
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of pyrvinium pamoate and posaconazole against
Li Y; Li S; Chen M; Xiao J; Fang H
Front Cell Infect Microbiol; 2022; 12():1074903. PubMed ID: 36569209
[TBL] [Abstract][Full Text] [Related]
10. Antifungal and Antibiofilm Activities of Selective Serotonin Reuptake Inhibitors Alone and in Combination with Fluconazole.
Tekintaş Y; Temel A; Ateş A; Eraç B; Metin DY; Hilmioğlu Polat S; Hoşgör Limoncu M
Turk J Pharm Sci; 2020 Dec; 17(6):667-672. PubMed ID: 33389969
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans/Cryptococcus gattii species complex.
Cordeiro RA; Evangelista AJJ; Serpa R; Marques FJF; Melo CVS; Oliveira JS; Franco JDS; Alencar LP; Bandeira TJPG; Brilhante RSN; Sidrim JJC; Rocha MFG
Microbiology (Reading); 2016 Feb; 162(2):309-317. PubMed ID: 26645478
[TBL] [Abstract][Full Text] [Related]
12. Reduced Susceptibility to Azoles in Cryptococcus gattii Correlates with the Substitution R258L in a Substrate Recognition Site of the Lanosterol 14-α-Demethylase.
Carvajal SK; Melendres J; Escandón P; Firacative C
Microbiol Spectr; 2023 Aug; 11(4):e0140323. PubMed ID: 37341584
[TBL] [Abstract][Full Text] [Related]
13. Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp.
da Silva AR; de Andrade Neto JB; da Silva CR; Campos Rde S; Costa Silva RA; Freitas DD; do Nascimento FB; de Andrade LN; Sampaio LS; Grangeiro TB; Magalhães HI; Cavalcanti BC; de Moraes MO; Nobre Júnior HV
Antimicrob Agents Chemother; 2016 Jun; 60(6):3551-7. PubMed ID: 27021328
[TBL] [Abstract][Full Text] [Related]
14. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
Warnock DW; Johnson EM; Rogers TR
J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyaldimines as potent in vitro anticryptococcal agents.
Magalhães TF; da Silva CM; de Fátima Â; da Silva DL; Modolo LV; Martins CV; Alves RB; Ruiz AL; Longato GB; de Carvalho JE; de Resende-Stoianoff MA
Lett Appl Microbiol; 2013 Aug; 57(2):137-43. PubMed ID: 23594040
[TBL] [Abstract][Full Text] [Related]
16. In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans.
Shrestha SK; Grilley M; Anderson T; Dhiman C; Oblad J; Chang CW; Sorensen KN; Takemoto JY
Med Mycol; 2015 Nov; 53(8):837-44. PubMed ID: 26260746
[TBL] [Abstract][Full Text] [Related]
17. Use of Pinus sylvestris L. (Pinaceae), Origanum vulgare L. (Lamiaceae), and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible Cryptococcus neoformans strains.
Scalas D; Mandras N; Roana J; Tardugno R; Cuffini AM; Ghisetti V; Benvenuti S; Tullio V
BMC Complement Altern Med; 2018 May; 18(1):143. PubMed ID: 29724221
[TBL] [Abstract][Full Text] [Related]
18. The role of Cryptococcus neoformans histone deacetylase genes in the response to antifungal drugs, epigenetic modulators and to photodynamic therapy mediated by an aluminium phthalocyanine chloride nanoemulsion in vitro.
Ranjan K; Brandão F; Morais JAV; Muehlmann LA; Silva-Pereira I; Bocca AL; Matos LF; Poças-Fonseca MJ
J Photochem Photobiol B; 2021 Mar; 216():112131. PubMed ID: 33517071
[TBL] [Abstract][Full Text] [Related]
19. Synergistic anticandidal activity of etomidate and azoles against clinical fluconazole-resistant
do Av Sá LG; da Silva CR; S Campos R; de A Neto JB; Sampaio LS; do Nascimento FB; Barroso FD; da Silva LJ; Queiroz HA; Cândido TM; Rodrigues DS; Leitão AC; de Moraes MO; Cavalcanti BC; Júnior HV
Future Microbiol; 2019 Nov; 14():1477-1488. PubMed ID: 31916846
[No Abstract] [Full Text] [Related]
20. Simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species.
Brilhante RS; Caetano EP; Oliveira JS; Castelo-Branco Dde S; Souza ER; Alencar LP; Cordeiro Rde A; Bandeira Tde J; Sidrim JJ; Rocha MF
Braz J Infect Dis; 2015; 19(5):459-65. PubMed ID: 26119850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
